ETFs positioned on Abbott Laboratories

Name YTD change Weight AuM
-.--%-.--% 1 M€
+4.20%-.--% 165 M€
+11.10%-.--% 67 M€
+17.56%-.--% 35,761 M€
+12.96%-.--% 122 M€
+7.42%-.--% 49 M€
+9.09%-.--% 143 M€
+1.82%-.--% 293 M€
+6.55%-.--% 37 M€
+7.71%-.--% 28 M€
+13.21%-.--% 1,674 M€
+11.86%-.--% 27,154 M€
+10.32%-.--% 66 M€
-18.83%18.52% 3,478 M€
-20.06%17.54% 234 M€
+8.17%7.18% 61 M€
-.--%4.99% 5 M€
+2.51%4.99% 4 M€
+0.82%4.99% 86 M€
+15.63%4.93% 513 M€
+7.74%4.77% 3,009 M€
-1.10%4.75% 33 M€
+30.56%4.32% 11 M€
+5.32%4.31% 941 M€
+6.60%4.19% 12 M€
+6.61%4% 28 M€
+7.68%3.89% 563 M€
+5.25%3.88% 140 M€
0.00%3.88% 9 M€
+7.35%3.77% 43,868 M€
+1.46%3.77% 56 M€
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ETFs Abbott Laboratories